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Radiation exposure in endovascular procedures
Erika R. Ketteler, MD, MA,a and Kellie R. Brown, MD,b Albuquerque, NM; and Milwaukee, Wisc
Background: The introduction of percutaneous techniques to treat patients with peripheral vascular disease has placed the
vascular surgeon in the unique role as the fluoroscopy supervisor overseeing the radiation protection for patient, self,
staff, and trainee. Since radiation is an invisible threat in endovascular interventions, attention to protection may be
challenging for the surgeon to understand and enforce.
Methods: General endovascular radiation considerations for endovascular aneurysm repair (EVAR) and peripheral
interventions are reviewed.
Results: Peripheral atherectomy has the highest estimated skin doses of all endovascular procedures. Renal interventions,
visceral balloon angioplasty and stenting, and embolization procedures are some of the procedures that have the highest
peak skin doses. Patients with high body mass index (BMI) have been found to have up to three times higher peak skin
doses than patients with normal BMI.
Conclusion: The degree of radiation exposure is dependent on the type of endovascular procedure, the patient’s body
habitus, and also the safety habits of the surgeon. Radiation exposure needs addressed in an informed consent process as
is required for other procedures. Radiation exposure risks also need monitoring just as a surgeon monitors individual
morbidity and mortality. ( J Vasc Surg 2011;53:35S-38S.)Endovascular treatment of vascular diseases is a para-
digm shift for intervention in many vascular conditions.1
Minimally-invasive methods are desired by both patients
and vascular interventionalists since endovascular therapy
can diminish the length of stay while reducing morbidity
and mortality in vascular patients, who often have many
comorbidities. Endovascular intervention has become such
an important component of vascular practice that studies
have shown in aneurysm surgery alone 50% of elective
aneurysm repairs are now performed via endovascular tech-
niques;1 in some institutions, even half of ruptured aneu-
rysms may be treated using endovascular protocol ap-
proaches.2 Besides endovascular aortic aneurysm repair
(EVAR), other realms of vascular disease such as the lower
extremity, carotids, mesenteric vessels, and the venous sys-
tem are also being approached using fluoroscopic radio-
logic guidance. Like cardiac catheterization, some of these
procedures can involve a high level of radiation exposure as
fluoroscopy is used to localize the lesion, monitor the
procedure, and control and document the end result.3
Radiation exposure is an accepted and necessary aspect of
modern medical practice, but there may be over 100 deaths
annually as a direct result of radiation use for diagnosis and
treatment.1 So while attending to the procedure and needs
of the patient, the vascular surgeon is placed in a unique
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protection for patients, self, staff, and any trainees. Since
radiation is an invisible threat in endovascular interven-
tions, attention to protection may be challenging for the
surgeon to understand and enforce. This section will ad-
dress-specific considerations for radiation exposure in en-
dovascular procedures and offers suggestions to minimize
the risks of radiation while maximizing the benefits of
radiation-guided vascular interventions.
GENERAL ENDOVASCULAR MEASUREMENT
AND RADIATION CONSIDERATIONS
“You can’t measure it if you can’t record it.”4 As
highlighted, the key to understanding the safety profile of
radiation is to have effective means of measuring. As shown
in the prior sections to this supplement, there are threshold
doses for radiation skin injury (2 Gy for erythema and 3 Gy
for hair loss).1 Individual biologic variation “in radiation
sensitivity and the presence of coexisting disease such as
diabetes mellitus and connective tissue disorders” add to
the injury risks of radiation4 andmust be taken into account
on a patient-by-patient basis during endovascular interven-
tions.
A common way to measure and collect the endovascu-
lar radiation data is via real-time dosimetric methods. These
real-time measurements are either by overall measurements
or by point-in-time measurements.1 Overall measurements
include DAP (dose area product), fluoroscopy time, and
reference point cumulation dosing. The problem with
overall measurements is that they are indirect estimations,
and are not ideally precise. On the other hand, point
measurements are direct and precise but are often difficult
to use.
The only method of dose measurement required by the
FDA is fluoroscopy time. Fluoroscopy equipment has
devices to measure fluoroscopy time, but these timers are
not ideal. They “provide a poor analogue of dose as they
provide no information regarding x-ray field size or posi-
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technique, or patient size.”1 DAP is an example of this, and
the poor estimation is seen when you realize that “a large
dose delivered to a small skin area yields the same DAP as a
small dose delivered to large skin area. Estimation of ab-
sorbed skin dose from DAP data has a potential error of at
least 30% to 40%.”1 The best measurement would be a
method that shows cumulative radiation dose in real-time.
Devices that measure cumulative radiation dose are cur-
rently available as probes, semiconducting transistors, or
scintillation dosimeters. However, these measurement de-
vices have to be placed accurately to obtain accurate mea-
surements.
Interventionalists need to realize that the type of imag-
ing equipment used may also impact the radiation dosing.
Geijer and colleagues found that “EVAR with [a portable]
C-arm results in dose values in the same range as coronary
interventions, which are known to have significant radia-
tion exposure. If the same patients had been treated using
dedicated angiographic equipment with higher radiation
output, the risk of skin injury would have been much
higher.”5 Care in technique as well as being aware of
equipment characteristics and limitations will assist in pre-
venting undue radiation exposure and complications.
The best measurement technique to date for real-time
radiation dose evaluation is using “skin-dose software that
models table height and position, gantry angle and posi-
tion, collimator size and position, and DAP. In addition,
patient characteristics of height, weight, and place on the
table are used to create a model of the patient’s skin surface.
A real-time continuous radiation dose is calculated to pro-
vide feedback to the surgeon so adjustments can bemade to
reduce the radiation exposure as much as possible.”1 Being
proactive as a fluoroscopy supervisor involves making radi-
ation safety as important as blood-borne safety. This means
that when new equipment is available that has dose-
reduction technology “protection should not be sacrificed in
the interest of economy.”1 Just as a leaky ceiling would not
be tolerated in an operating room, neither should we
tolerate suboptimal fluoroscopy equipment when appropri-
ate devices are available and can impact patients’ radiation
safety.
Until advanced software measurement devices as de-
scribed above are available to all surgeons engaging in
fluoroscopy diagnosis and treatment, there are useful direc-
tives to assist in reducing radiation exposure to vascular
patients while being able to achieve quality imaging. Tech-
niques under the surgeon’s control are aggressive uses of
intermittent fluoroscopy, last-image hold, and collimation.
Other ideal fluoroscopy habits should include reducing the
air-gap between the patient and intensifier, changing the
gantry angle frequently, and limiting magnification views.1
To further reduce the radiation risks, the surgeon can
employ higher kilovolt and lower milliampere settings and
implement anti-scatter grids.6 Pulsed fluoroscopy at “15 or
7.5 pulses per second decreases the fluoroscopy dose . . . by
47% and 72%, respectively.”4 Pulsing is needed to avoid
blurred images by counteracting the “pulsating motion ofblood vessels and the vibrating motion of a catheter wire.”7
Most important in reducing radiation dose, however, is
limiting digital subtraction imaging.8 Within this recom-
mendation and the prior caveats, the surgeon needs to
gauge how much “noise” (nonoptimal imaging) is allow-
able to effectively diagnose and treat the vascular condition.
With careful pre-planning and continual intraoperative as-
sessment, the radiation dose to the patient can be greatly
reduced by keeping in mind that not every image needs to
be perfect, rather just precise enough to effectively detect
the problem, intervene, and follow-up appropriately.
VASCULAR PROCEDURE RADIATION
SPECIFICS RELATED TO PROCEDURE
Despite the above limitations of radiation dose mea-
surements and the unique operator variations in fluoro-
scopic technique, some researchers have attempted to
quantify radiation doses for vascular procedures to make
recommendations to optimize radiation safety. Prior to
these endovascular-specific studies, much of the endovas-
cular radiation risks were extrapolated from cardiac cathe-
terization doses or interventional neuroradiology data.
Deeming EVAR interventions as major fluoroscopic proce-
dures, this was one of the first vascular surgery procedures
to be evaluated for radiation dosing. Kalef and colleagues
found the standard EVAR radiation dose to be 0.82 Gy,
measured via peak skin dosing using C-arm with a specific
radiation table set-up.3 Geiger and colleagues found that in
24 patients undergoing EVAR, the skin dose was 0.33 Gy,
with median effective dose of 8.7 mSV (bymobile and fixed
imaging with actual and simulated data).5 These radiation
doses may not be clinically realistic as they may not include
EVAR procedures with less than straight-forward anatomy.
Weerakkody and colleagues addressed this topic and
showed in their study of 96 patients that “in addition to
fluoroscopic screening [images], each [EVAR] procedure
required between six and eight angiographic views . . . with
23 of 96 patients having iliac disease requiring intervention
and 5 patients [needing] branched grafts.”9 Of the 96
patients, 29% exceeded the 2-Gy threshold dosing. The
authors believed that skin erythema from such doses may
have been missed because it was subtle or may have oc-
curred late and was seen by other practitioners such as
dermatology.9
Regarding lower extremity peripheral endovascular in-
terventions, atherectomy has the highest estimated skin
doses (nearly 1.5 Gy) of all endovascular interventions
(including aortic and carotid).6 Regarding nonextremity
interventions, Miller and colleagues found that overall peak
skin doses were highest for renal interventions, followed
by visceral ballooning/stenting, followed by transjugu-
lar intrahepatic portosystemic shunt, and finally emboli-
zation procedures.4
The above studies have addressed the deterministic risk
to patients during and around the endovascular interven-
tional period. The stochastic risk, as manifested by malig-
nancy, is not to be forgotten. A recent estimate, from a
United Kingdom study, is that over 700 cases of cancer per
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cancers per 100,000 interventional cardiology proce-
dures.1 Estimated lifetime fatal cancer risk per type of
procedure can be 1% for EVAR and near 1% for an
endovascular treatment of a thoracic aneurysm with ap-
proximately 0.5% fatal cancer risk for atherectomy.6 Of
course, the age of the patient undergoing fluoroscopic
imaging is an important consideration, as the time to
manifest some radiation-induced cancers is longer than
some vascular patients’ survival. However, many vascular
patients may need follow-up radiologic imaging (CT scans
for EVAR) or other diagnostic and therapeutic procedures
such as coronary catheterization. Thus, the cancer risk to
the patient is not low.
As mentioned, patient-specific characteristics can im-
pact further radiation dosing and risk. Weiss and colleagues
evaluated BMI (body mass index) in patients undergoing
EVAR and found that obese patients had up to three times
higher DAP and peak skin doses then patients with a
normal BMI.10 With increasing obesity in the population,
careful consideration must be made to BMI as a risk factor
for fluoroscopic imaging complication, and procedures
need to be adjusted accordingly.
Recognizing all of the radiation risks to the patient
related to imaging techniques, equipment, the particular
therapeutic procedure, as well as unique patient character-
istics, we must consider whether our vascular surgery pa-
tients need to be consented for the radiation exposure they
will receive during the intervention and in the follow-up
period. Given that we talk to patients about risk of transfu-
sion and anesthesia, it is reasonable to believe that it is our
duty to also make patients aware of the risks of radiation
and place it in perspective relative to the risk/benefit of not
undergoing the endovascular procedure. Some have indi-
cated that any patient undergoing a procedure involving
expected radiation over 2 Gy should be consented for
radiation exposure. As it is often difficult to predict the
amount of expected exposure, radiation exposure risk
should be a standard component of the preoperative in-
formed consent discussion.
STAFF RADIATION EXPOSURE
The risk of radiation to our patients is obvious, but we
must not forget the risk fluoroscopy has on the surgeons,
staff, and trainees. As we aggressively strive to reduce
patient doses, we will in turn effectively reduce surgeon and
staff doses.3 A 3-minute prolongation of fluoroscopy treat-
ment causes about 20 Gy cm2 increase in DAP.8 Thus
vigilance on the part of the operator is vital, and we must
ensure that our operators have adequate radiation safety
training. This policy in radiation protection is as important
as equipment design.4
So what is the radiation risk to the interventionalist
performing fluoroscopy? A few studies have addressed this
topic, although the limitations of radiation measurement
limit the accuracy. Surgeons who perform EVAR have been
shown to have the highest radiation exposure to body, eye,
and hand.11 “Assuming similar fluoroscopic settings andradiation protection devices were applied and calculated
from mean body dose per procedure, a single vascular
surgeon would have to perform 2597 EVARs, 6897 arte-
riograms, or 6451 balloons/stents before reaching the
dose limit”11 recommended by the International Commis-
sion on Radiation Protection (ICRP). Radiation exposure
to the hand was the most variable between surgeons in
Ho’s study and may be a function of experience and hand-
injection techniques. Lipsitz and colleagues found slightly
higher eye and hand radiation doses compared to Ho and
colleagues, and this was felt to be attributable to the use of
table-side lead shield and/or amobile lead shield.12 Reduc-
tion of surgeon and staff exposure is achieved through
vigilance, and the use of all available modalities and tech-
niques to limit the radiation dose. Shorter stature surgeons
and staff need to realize they may be exposed to more
radiation due to proximity to the radiation source and
patient scatter; therefore, shorter individuals should try to
compensate accordingly. Using power injection when pos-
sible so surgeon and staff can move a distance away during
digital subtraction imaging can significantly decrease an
operator’s exposure. Layton and colleagues showed that if
the fluoroscopy “operator stood back 5 meters from table,
all the dose from DSA [digital subtraction imaging] could
be eliminated . . . [but of operators] who routinely hand-
injected . . . 75% of their radiation dose came from
DSA.”13 Vascular surgeons should develop habits that
protect their patient, their staff, and themselves. In addi-
tion, vascular surgeons should investigate and support new
imaging modalities such as duplex-guided vascular inter-
ventions11 tomake radiation exposure as little as reasonably
appropriate—the well-known acronym: ALARA.
SUMMARY
There are many obstacles in standardizing radiation
exposure in endovascular interventions. Measuring radia-
tion by either direct or indirect means has limitations.
Updates in future software programs and in fluoroscopy
hardware will assist the surgeon and team in providing
optimal radiation protection to the patient and the surgical
team. The onus currently lies on the surgeon to continually
monitor and adjust the radiation exposure to the patient,
self, and staff. This also means the surgeon must be sure the
team members understand the appropriate protection fea-
tures and must insist on adherence to policies and proce-
dures. A robust protocol of radiation exposure measure-
ment must be implemented, and should include everyone
involved in the fluoroscopy suite.
As shown in this review, the degree of radiation expo-
sure is dependent on the type of endovascular procedure,
the body habitus of the patient, and also the safety habits of
the surgeon controlling the radiation pedal. Just as sur-
geons monitor their individual morbidity and mortality,
the endovascular surgeon needs tomonitor his or her use of
radiation and develop protocols to reduce the radiation
risks. This concept is vitally important for the patient be-
cause endovascular procedures that have a high intraoper-
ative exposure will often need additional radiation for post-
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interventions become more complex and common (such as
fenestration for abdominal aortic aneurysm), then the
amount of radiation given during these longer procedures
will also increase. Immediate deterministic risks of skin
injury will then likely be more prevalent, and the stochastic
exposure will increase for both patient and staff. Surgeons
will need constant “audit and feedback”14 as more ad-
vanced fluoroscopic procedures enter the realm of vascular
interventional procedures. Even though dose monitoring
has limitations, the focus on a robust protocol to monitor
radiation over time is important so changes can be imple-
mented. A good policy7 for dose monitoring is to measure
radiation dose:
● For any procedure that may utilize more than 20
minutes of fluoroscopy
● For any procedure that potentially involves direct irra-
diation of the pelvis of a pregnant patient
● Periodically to assess that radiation doses are in accept-
able norms
● For training purposes
More research is needed by the vascular surgery commu-
nity to critically evaluate our policies and procedures, and to
determine what degree of fluoroscopic imaging is needed for
our interventions and follow-up. As new data and techniques
are available, we need to implement these to make radiation
exposure as little as reasonably appropriate (ALARA). Achiev-
ing these goals will require guidance from thosewith radiation
expertise, informed awareness of radiation risks by our pa-
tients, staff, and trainees, and constant monitoring and re-
evaluation in day-to-day fluoroscopic practice.
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